Top

Neurological Sciences

Published in:

01-07-2020 | Rituximab | Letter to the Editor

Aggressive anti-LGI1 encephalitis defeated by one cycle of intravenous rituximab—a case report

Authors: Ivana Markovic, Silvio Basic, Sabina Devedjija

Published in: Neurological Sciences | Issue 7/2020

Excerpt

Dear Editor-in-Chief, …

Khadilkar S, Soni G, Patil S, Huchche A, Faldu H (2017) Autoimmune encephalitis: an update. J Assoc Physicians India 65(2):62–69PubMed

Wang M, Cao X, Liu Q, Ma W, Guo X, Liu X (2017) Clinical features of limbic encephalitis with LGI1 antibody. Neuropsychiatr Dis Treat 13:1589–1596. https://doi.org/10.2147/NDT.S136723

Ariño H, Armangué T, Petit-Pedrol M, Sabater L, Martinez-Hernandez E, Hara M, Lancaster E, Saiz A, Dalmau J, Graus F (2016) Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology 87(8):759–765. https://doi.org/10.1212/WNL.0000000000003009

Shin YW, Lee ST, Park KI, Jung KH, Jung KY, Lee SK, Chu K (2018) Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord 11:1–19. https://doi.org/10.1177/1756285617722347

Saigal K, Valencia IC, Cohen J, Kerdel FA (2003) Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximab. J Am Acad Dermatol 49(5):283–285. https://doi.org/10.1016/s0190-9622(03)00744-8

Hidemasa N, Hiroshi Y, Maiko H, Ichiro M (2019) Rapid response to low-dose rituximab following development of severe hemophagocytic lymphohistiocytosis due to Epstein-Barr virus infection. Int J Clin Pediatr 8(1):8–11. https://doi.org/10.14740/ijcp325

Lamar Z, Kennedy L, Kennedy B, Lynch M, Goad A, Hurd D, McIver Z (2015) Ibrutinib and rituximab induced rapid response in refractory Richter syndrome. Clin Case Rep 3(7):615–617. https://doi.org/10.1002/ccr3.269

Ogilvie J, Singh J (2018) A dramatic recovery in a patient initially expected to die of TTP & its complications. J Community Hosp Intern Med Perspect 8(3):142–144. https://doi.org/10.1080/20009666.2018.1475186

Webster D, Ritchie B, Mant MJ (2004) Prompt response to rituximab of severe hemolytic anemia with both cold and warm autoantibodies. Am J Hematol 75(4):258–259. https://doi.org/10.1002/ajh.20034

10.

Simms-Waldrip T, Ikeda A, Goldfinger D, Moore T, Yuan S (2010) Dramatic response to rituximab in a child with severe cold autoimmune hemolytic anemia arising after allogeneic hematopoietic SCT. Bone Marrow Transplant 45:201–202. https://doi.org/10.1038/bmt.2009.108

Title: Aggressive anti-LGI1 encephalitis defeated by one cycle of intravenous rituximab—a case report
Authors: Ivana Markovic
Silvio Basic
Sabina Devedjija
Publication date: 01-07-2020
Publisher: Springer International Publishing
Keywords: Rituximab
Autoimmune Encephalitis
Encephalitis
Rituximab
Published in: Neurological Sciences / Issue 7/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-020-04264-1

At a glance: The STEP trials

Springer Medicine

Aggressive anti-LGI1 encephalitis defeated by one cycle of intravenous rituximab—a case report

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2020

Keep “time is brain,” even in the crisis of COVID-19

Contrast sensitivity impairment in drug-naïve Parkinson’s disease patients associates with early cognitive decline

Spectral domain OCT can differentiate the retinal morphological changes of patients with Parkinson’s disease in clinical middle stages

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study

The neurological manifestations of COVID-19: a review article

Association of depressive symptoms with decline of cognitive function—Rugao longevity and ageing study